Is SPRAX or JNJ a better dividend investment in 2026?

SPRAX currently yields 1.11% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between SPRAX and JNJ?

SPRAX has a forward dividend yield of 1.11% ($0.31/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2.25 percentage points.

Home › Compare › SPRAX vs JNJ

SPRAX vs JNJ: Dividend Comparison 2026

SPRAX yields 1.11% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SPRAX wins by $1.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SPRAX

● Live price

1.11%

Share price

$27.64

Annual div

$0.31

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.3K

Annual income

$119.21

Full SPRAX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SPRAX vs JNJ

📍 SPRAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SPRAX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SPRAX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SPRAX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPRAX

Annual income on $10K today (after 15% tax)

$94.29/yr

After 10yr DRIP, annual income (after tax)

$101.33/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $602.28/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPRAX + JNJ for your $10,000?

SPRAX: 50%JNJ: 50%

100% JNJ50/50100% SPRAX

Portfolio after 10yr

$20.6K

Annual income

$473.49/yr

Blended yield

2.29%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPRAX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPRAX buys

JNJ buys

No recent congressional trades found for SPRAX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSPRAXJNJ

Forward yield	1.11%	3.36% ✓
Annual dividend / share	$0.31	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$21.3K ✓	$20.0K
Annual income after 10y	$119.21	$827.78 ✓
Total dividends collected	$1.2K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SPRAX vs JNJ ($10,000, DRIP)

Year	SPRAX Portfolio	SPRAX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$10,811	$110.93	$10,676	$355.77	+$135.00 → SPRAX
2	$11,680	$112.08	$11,407	$389.39	+$273.00 → SPRAX
3	$12,611	$113.17	$12,198	$426.53	+$413.00 → SPRAX
4	$13,607	$114.19	$13,056	$467.62	+$551.00 → SPRAX
5	$14,675	$115.16	$13,987	$513.12	+$688.00 → SPRAX
6	$15,818	$116.07	$14,998	$563.56	+$820.00 → SPRAX
7	$17,043	$116.93	$16,098	$619.52	+$945.00 → SPRAX
8	$18,353	$117.73	$17,295	$681.69	+$1.1K → SPRAX
9	$19,757	$118.49	$18,599	$750.82	+$1.2K → SPRAX
10	$21,259	$119.21	$20,022	$827.78	+$1.2K → SPRAX

SPRAX vs JNJ: Complete Analysis 2026

SPRAX — Stock

The fund normally invests at least 80% of its investable assets in equity and equity-related securities of mid-cap companies. The sub-adviser considers mid-cap companies to be companies with market capitalizations within the market cap range of companies included in the Russell Midcap Index (measured at the time of purchase). Most of the fund's assets will typically be invested in U.S. equity and equity-related securities, including up to 25% of its total assets in real estate investment trusts ("REITs").

Full SPRAX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SPRAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPRAX vs SCHD SPRAX vs JEPI SPRAX vs O SPRAX vs KO SPRAX vs MAIN SPRAX vs ABBV SPRAX vs MRK SPRAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.